Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Not Confirmed
Not Confirmed
05-08 October, 2024
Not Confirmed
Not Confirmed
06-09 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Industry Trade Show
Not Confirmed
05-08 October, 2024
Industry Trade Show
Not Confirmed
06-09 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
26 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/26/2953812/0/en/Reviva-Pharmaceuticals-to-Participate-in-the-Lytham-Partners-Fall-2024-Investor-Conference.html
09 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/09/2942764/0/en/Reviva-Announces-New-Vocal-Biomarker-Data-from-Phase-3-RECOVER-Trial-of-Brilaroxazine-in-Schizophrenia.html
04 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/04/2940452/0/en/Reviva-to-Participate-in-the-H-C-Wainwright-26th-Annual-Global-Investment-Conference.html
27 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/27/2936186/0/en/Reviva-to-Host-Virtual-KOL-Event-to-Discuss-Vocal-Biomarker-Data-from-Phase-3-RECOVER-Trial-of-Brilaroxazine-in-Schizophrenia-on-September-4-2024.html
21 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/21/2933345/0/en/Reviva-Pharmaceuticals-Announces-Pricing-of-5-0-Million-Underwritten-Offering-Priced-At-the-Market-Under-Nasdaq-Rules.html
14 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/14/2930028/0/en/Reviva-Reports-Second-Quarter-2024-Financial-Results-and-Recent-Business-Highlights.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?